MWM
ABBV icon

MBE Wealth Management’s AbbVie ABBV Stock Holding History

MBE Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Sell
5,424
-41
-0.8% -$8.82K 0.48% 33
2026
Q1 		$1.19M Buy
5,465
+70
+1% +$15.5K 0.49% 33
2025
Q4 		$1.23M Sell
5,395
-24
-0.4% -$5.47K 0.52% 32
2025
Q3 		$1.25M Buy
5,419
+225
+4% +$45.8K 0.54% 31
2025
Q2 		$964K Buy
5,194
+2
+0% +$372 0.42% 34
2025
Q1 		$1.09M Buy
5,192
+244
+5% +$47.4K 0.52% 30
2024
Q4 		$879K Sell
4,948
-567
-10% -$104K 0.5% 29
2024
Q3 		$1.09M Buy
5,515
+1
+0% +$187 0.6% 28
2024
Q2 		$946K Sell
5,514
-140
-2% -$23.2K 0.57% 29
2024
Q1 		$1.03M Sell
5,654
-2,223
-28% -$383K 0.64% 26
2023
Q4 		$1.22M Buy
7,877
+1
+0% +$146 0.62% 21
2023
Q3 		$1.17M Buy
7,876
+1
+0% +$147 0.67% 19
2023
Q2 		$1.06M Buy
7,875
+478
+6% +$70.1K 0.57% 25
2023
Q1 		$1.18M Sell
7,397
-234
-3% -$35.8K 0.69% 19
2022
Q4 		$1.23M Buy
7,631
+2,907
+62% +$446K 0.8% 16
2022
Q3 		$634K Sell
4,724
-300
-6% -$43K 0.46% 22
2022
Q2 		$769K Sell
5,024
-141
-3% -$21.5K 0.54% 20
2022
Q1 		$837K Hold
5,165
– – 0.5% 21
2021
Q4 		$699K Buy
5,165
+42
+0.8% +$4.96K 0.36% 23
2021
Q3 		$553K Buy
5,123
+119
+2% +$13.6K 0.28% 22
2021
Q2 		$564K Buy
5,004
+92
+2% +$10.4K 0.29% 24
2021
Q1 		$532K Sell
4,912
-219
-4% -$23.4K 0.29% 33
2020
Q4 		$549K Buy
5,131
+296
+6% +$28.4K 0.37% 30
2020
Q3 		$474K Hold
4,835
– – 0.4% 27
2020
Q2 		$474K Buy
4,835
+3,952
+448% +$348K 0.4% 27
2020
Q1 		$67K Buy
+883
New +$75.2K 0.06% 94

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

MBE Wealth Management's ABBV Position: Q2 2026 in Review

MBE Wealth Management reduced its AbbVie (ABBV) stake by 0.75% in Q2 2026, selling an estimated $8.82K and leaving 5,424 shares worth $1.36M. The position accounts for 0.48% of the portfolio, ranked #33.

MBE Wealth Management first reported a position in ABBV in Q1 2020 and has held it in 26 quarters since. 1,993 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • MBE Wealth Management held 5,424 shares of AbbVie worth $1.36M as of Q2 2026.
  • MBE Wealth Management sold 41 AbbVie shares in Q2 2026, an estimated $8.82K.
  • AbbVie made up 0.48% of MBE Wealth Management's portfolio in Q2 2026, its #33 holding.
  • MBE Wealth Management first reported a position in AbbVie in Q1 2020 and has held it in 26 quarters since.
  • 1,993 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on MBE Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.